Search

everythinglearnresearchcommunity

for

Search:↓

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Enhanced stem cells can reduce fat buildup in eye tissue for Graves' disease.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

GRF is not safe for tubal occlusion.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

Isoliensinine, a natural compound, prevents stress-related hair greying by blocking a specific receptor on hair cells.

Compound 7p shows strong potential as an anticancer agent.

Nonactivated low leukocyte PRP injections can significantly increase hair and follicle density in women with alopecia.

Finasteride may help improve certain brain function issues linked to dopamine.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

New compounds may help treat prostate issues without affecting androgen receptors.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Inhibiting plant sterols reduces grapevine pathogen reproduction.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

No treatment showed clear superiority for lichen planopilaris.